Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue
Posted in: Trading Ideas
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue.
The trailing-twelve-month revenue at Neogen Corporation (NASDAQ: NEOG) is $172.68 million. NEOG's PEG ratio is 1.53.
The trailing-twelve-month revenue at Meridian Bioscience Inc (NASDAQ: VIVO) is $153.91 million. VIVO's operating margin for the same period is 26.83%.
The trailing-twelve-month revenue at Quidel Corporation (NASDAQ: QDEL) is $147.04 million. QDEL had $65.30 million in total cash for the recent quarter.
The trailing-twelve-month revenue at ABAXIS Inc (NASDAQ: ABAX) is $144.73 million. ABAX's ROE for the same period is 8.18%.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
